The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Fri., Jul. 31, 9:27 PM

Slide #3. EyeGate Pharmaceuticals, Inc. Secondary Offering

Company: EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG)
Date announced: 7/30/2015
Shares Offered: 1,176,470
Date of Pricing: 7/30/2015
Price Per Share: $8.50
Secondary Offering Details: EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (NASDAQ:EYEGW) ("EyeGate" or the "Company"), a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye, today announced the pricing of an underwritten public offering of 1,176,470 shares of its common stock and warrants to purchase up to 1,176,470 shares of its common stock, at a combined price to the public of $8.50 per one share of common stock and warrant to purchase one share of common stock. The warrants have a per share exercise price of $10.62, are exercisable immediately, and expire five years from the date of issuance. The gross proceeds to EyeGate from this offering are expected to be approximately $10,000,000, before deducting underwriting discounts and commissions and other estimated offering expenses. As a result of the offering, the Company's common stock and warrants will become listed on the NASDAQ Capital Market and will trade separately under the ticker symbols "EYEG" and "EYEGW," respectively, beginning on July 31, 2015. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 176,470 shares of common stock and/or warrants to purchase up to 176,470 shares of our common stock. The offering is expected to close on August 5, 2015, subject to customary closing conditions.

  EyeGate Pharmaceuticals, Inc.: trading symbol EYEG

Open the EYEG Page at The Online Investor (in a new window) »

July 31, 2015    9:27 PM Eastern
Quotes delayed 20 minutes

Secondary Stock Offerings | | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.